Herpes Zoster: Risk Factors, Complications and Special Situations
NCT03903237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 355
Last updated 2019-04-04
Summary
This retrospective analysis is to investigate patients' history and clinical presentation in Herpes Zoster (HZ), Zoster-related complications, post-Zoster neuralgia and Herpes Zoster management in order to improve the management of HZ patients, to refine HZ-vaccination strategies and elucidate cost factors of HZ in in the setting of a university hospital in Switzerland generally and in a dermatology department specifically.
Conditions
- Herpes Zoster
Interventions
- OTHER
-
retrospective chart review
retrospective report review of HZ patients treated between 2005 and 2018 in the Department of Dermatology at the University Hospital Basel
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Simon Müller, Dr. med · Department of Dermatology, University Hospital Basel
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-20
- Primary Completion
- 2019-02-28
- Completion
- 2019-02-28
Countries
- Switzerland
Study Locations
More Related Trials
-
Shingles Prevention Study
NCT00007501 ·Status: COMPLETED ·Phase: PHASE3
-
Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France
NCT02487472 ·Status: COMPLETED
-
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
NCT01915212 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
NCT00689013 ·Status: COMPLETED ·Phase: NA
-
Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain
NCT01521286 ·Status: COMPLETED
-
HSV Oral Reactivation in Children
NCT01878279 ·Status: COMPLETED
-
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
NCT01165203 ·Status: COMPLETED ·Phase: PHASE2
-
Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
NCT00698490 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
NCT00698568 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
NCT02090803 ·Status: COMPLETED
-
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
NCT00697567 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
NCT00224471 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster
NCT02151240 ·Status: COMPLETED ·Phase: PHASE4
-
Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage
NCT06334861 ·Status: COMPLETED
-
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
NCT01519570 ·Status: COMPLETED ·Phase: NA
-
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
NCT06903078 ·Status: RECRUITING
-
Herpes Simplex Reactivation in Adult Critical Care Patients
NCT02322476 ·Status: UNKNOWN
-
Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital
NCT01483378 ·Status: COMPLETED ·Phase: NA
-
A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
NCT00900783 ·Status: COMPLETED ·Phase: PHASE2
-
Review of Human Herpes Viruses in Burns
NCT02452229 ·Status: COMPLETED
-
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems
NCT00002315 ·Status: COMPLETED ·Phase: PHASE3
-
RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir
NCT00219310 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
NCT05298254 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
NCT05492591 ·Status: COMPLETED ·Phase: PHASE2
-
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
NCT00486200 ·Status: COMPLETED ·Phase: PHASE2